Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 4th Quarter 2024 Results Denver, Colorado, February 13, 2025 — DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25 annivers ...

DENVER, Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended December 31, 2024."Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25th anniversary of DaVita, we look forward to continuing our efforts to improve clinical outcomes, enh ...

DaVita Inc. (DVA) is scheduled to report fourth-quarter 2024 results on Feb. 13, after the closing bell.See the Zacks Earnings Calendar to stay ahead of market-making news.In the last reported quarter, the company’s earnings per share (EPS) of $2.59 lagged the Zacks Consensus Estimate by 6.2%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on three occasions and missed once, delivering an earnings surprise of 10.6%, on average.For fourth-quarter 2024, the Zacks Conse ...

In the latest trading session, DaVita HealthCare (DVA) closed at $177.35, marking a +0.16% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.72% for the day. Elsewhere, the Dow gained 0.3%, while the tech-heavy Nasdaq added 1.35%.The kidney dialysis provider's stock has climbed by 16.85% in the past month, exceeding the Medical sector's gain of 4.51% and the S&P 500's gain of 1.02%.Investors will be eagerly watching for the performance of DaVita HealthCare in its ...

DENVER, Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Thursday, February 13, 2025Starting at 5:00 p.m. ESTWebcast can be accessed using this link Dial in num ...

DaVita HealthCare (DVA) closed the most recent trading day at $173.77, moving +0.32% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.47%. On the other hand, the Dow registered a loss of 0.31%, and the technology-centric Nasdaq decreased by 0.51%.Coming into today, shares of the kidney dialysis provider had gained 15.82% in the past month. In that same time, the Medical sector gained 3.2%, while the S&P 500 gained 1.67%.Analysts and investors alike wi ...

Investors might want to bet on DaVita HealthCare (DVA) , as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a ch ...

Big things happened this weekend.In a calculated move, a Chinese AI company released its newest large-language model (LLM), on the same day as the presidential inauguration. Though it took a week for most market participants to take notice, all are now paying attention. DeepSeek, the latest contender in the AI landscape, has made waves by developing an equally powerful algorithm at a fraction of the cost—and it’s open-source. The implications of this are quite significant, as is evident from the price actio ...

In the latest trading session, DaVita HealthCare (DVA) closed at $169.90, marking a +0.86% move from the previous day. This move outpaced the S&P 500's daily gain of 0.53%. Meanwhile, the Dow gained 0.93%, and the Nasdaq, a tech-heavy index, added 0.22%.Shares of the kidney dialysis provider have appreciated by 8.64% over the course of the past month, outperforming the Medical sector's gain of 1.49% and the S&P 500's gain of 2.69%.The investment community will be paying close attention to the earnings perfo ...

For Immediate ReleaseChicago, IL – January 17, 2025 – Today, Zacks Equity Research Equity Quest Diagnostics Inc. (DGX) , DaVita Inc. (DVA) , Option Care Health, Inc. (OPCH) and Addus HomeCare Corp. (ADUS) .Industry: Outpatient and Home HealthcareLink: https://www.zacks.com/commentary/2398152/4-stocks-to-monitor-in-a-dynamic-outpatient-home-health-industryThe Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, t ...